Entelos Holding Corporation
Latest round
- Series C
Last raised
- Sep 2001
Total raised
- $40M
Investors
- 9
About Entelos Holding Corporation
Entelos Holding Corporation is focused on providing innovative biosimulation software solutions.Entelos Predictive Biosimulation specializes in advanced software solutions designed to enhance drug research and development by providing comprehensive predictive modeling and mapping capabilities. Their core offerings include a sophisticated software platform that simulates system biology of virtual human patients and populations, enabling accurate identification and translation of biomarkers. This technology aids in optimizing clinical trial design, patient stratification, and therapeutic targeting. The company primarily serves pharmaceutical and biotechnology firms engaged in drug development, particularly in areas such as type II diabetes, rheumatoid arthritis, cardiovascular diseases, and dermatology.Entelos generates revenue through a business model centered on B2B transactions, providing software services and expert consulting to its clients in the pharmaceutical and biotechnology sectors. The company engages in partnerships and subscription-based agreements, allowing clients to access its comprehensive biosimulation tools and predictive analytics. Revenue is derived from the deployment of its flagship software platform, which includes mechanism-based mathematical models and biosimulation technology, tailored to each client's specific trial needs.Entelos Holding Corporation plans to launch new features in its software platform aimed at improving user experience and expanding its capabilities by the end of the next fiscal year. The company is also targeting expansion into Asian markets, particularly Japan and South Korea, by 2025.
Who invested in Entelos Holding Corporation
9 investors across 2 rounds
See all investors in Entelos Holding Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Entelos Holding Corporation
Who invested in Entelos Holding Corporation?
Entelos Holding Corporation has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Entelos Holding Corporation raised?
Entelos Holding Corporation has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Entelos Holding Corporation last raise money?
Entelos Holding Corporation's most recent round on record is a Series C, in Sep 2001.
What does Entelos Holding Corporation do?
Entelos Holding Corporation is focused on providing innovative biosimulation software solutions.
Where is Entelos Holding Corporation headquartered?
Entelos Holding Corporation is headquartered in San Mateo, US.
Which VCs invest in companies like Entelos Holding Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Entelos Holding Corporation's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like Entelos Holding Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.